focus -WSS

focus

author：comprehensive 2025-09-06 03:57:29 - browse：312

Bernard Moss, a research scientist at NIAID. -- Infectious disease coverage from STAT — Bernard Moss Courtesy NIAID

For more than half a century, scientist Bernard Moss has been commanding the attention of peers interested in prying biological secrets from poxviruses and other microbiological targets. Now he’s commanding the attention of a different audience: House Republicans.

Moss, who will mark his 86th birthday in late July and who goes by Bernie, has worked for more than 55 years in the laboratories of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. Over that time, he has been investigating viruses in relative anonymity — except, that is, among the virological cognoscenti.

But last year, in an interview with Science, Moss said he planned to try to determine why one strain of mpox viruses, known as Clade 1, is so much more virulent than those in a second strain, Clade 2, by taking genes from the former and putting them into the latter. Clade 2 viruses are responsible for the ongoing mpox outbreak first detected in May 2022.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： House transparency, PBM reform bill gains bipartisan support

focus

WSS

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

As demand for Covid shots wanes, Moderna seeks its next success

Medicare details structure of new drug price negotiation program

Wildfire smoke exposes gaps in outdoor worker protections

Snackable artificial intelligence, expert AI, and the pharma industry

Psychedelics group wrestles with new pharma identity

knowledge

focus

explore

How one medical school became remarkably diverse

Continuity nursing helped my family in our darkest PICU moments

Jerome Adams on the need for new antivirals for Covid

Medical leaders decry Supreme Court decision on affirmative action

Wildfire smoke exposes gaps in outdoor worker protections

Medicare details structure of new drug price negotiation program

Medicare proposal to cover medical devices draws a mixed reaction

In age of alternative facts, a scholarly course on calling out crap

Alkermes shareholders re

Illumina names Agilent executive as new CEO

focus

The (many) problems with a new study criticizing cancer screening

Psychedelics group wrestles with new pharma identity

A new House health package & hospitals’ new site

DIEP, the 'gold standard' of breast reconstruction, is under threat

Jerome Adams on the need for new antivirals for Covid

The 10 drugs up first for Medicare price negotiation

Wikipedia

hotspot

focus

knowledge